A nationwide clinical trial is focused on understanding and treating chronic hepatitis B infections among Asian populations in the U.S. Foreign-born Asian-Americans have a hepatitis B rate 20 times higher than the rest of the population, and public health officials are urging testing and early treatment.

Full Story:
The Seattle Times

Related Summaries